Literature DB >> 17941496

Association of multiple vertebral hemangiomas and severe paraparesis in a patient with a PTEN hamartoma tumor syndrome. Case report.

Benoit Jenny1, Ivan Radovanovic, Charles-Antoine Haenggeli, Jacqueline Delavelle, Daniel Rüfenacht, André Kaelin, Jean-Louis Blouin, Armand Bottani, Bénédict Rilliet.   

Abstract

The PTEN hamartoma tumor syndrome, manifestations of which include Cowden disease and Bannayan-Riley-Ruvalcaba syndrome, is caused by various mutations of the PTEN gene located at 10q23. Its major criteria are macrocephaly and a propensity to develop breast and thyroid cancers as well as endometrial carcinoma. Minor diagnostic criteria include hamartomatous intestinal polyps, lipomas, fibrocystic disease of the breasts, and fibromas. Mutations of PTEN can also be found in patients with Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). The authors report the case of a 17-year-old girl who had a severe cyanotic cardiac malformation for which surgery was not advised and a heterozygous missense mutation (c.406T>C) in exon 5 of PTEN resulting in the substitution of cysteine for arginine (p.Cysl36Arg) in the protein, which was also found in her mother and sister. The patient presented in the pediatric emergency department with severe spastic paraparesis. A magnetic resonance imaging study of the spine showed vertebral hemangiomas at multiple levels, but stenosis and compression were maximal at level T5-6. An emergency T5-6 laminectomy was performed. The decompression was extremely hemorrhagic because the rapid onset of paraparesis necessitated prompt treatment, and there was no time to perform preoperative embolization. The patient's postoperative course was uneventful with gradual recovery. This represents the first report of an association of a PTEN mutation and multiple vertebral angiomas. The authors did not treat the remaining angiomas because surgical treatment was contraindicated without previous embolization, which in itself would present considerable risk in this patient with congenital cyanotic heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941496     DOI: 10.3171/PED-07/10/307

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome".

Authors:  Martina Galatola; Lorella Paparo; Francesca Duraturo; Mimmo Turano; Giovanni Battista Rossi; Paola Izzo; Marina De Rosa
Journal:  BMC Med Genet       Date:  2012-04-20       Impact factor: 2.103

Review 2.  Tumor-to-tumor metastases in Cowden's disease: an autopsy case report and review of the literature.

Authors:  Karen Matsumoto; Kanae Nosaka; Tatsushi Shiomi; Yuki Matsuoka; Yoshihisa Umekita
Journal:  Diagn Pathol       Date:  2015-09-17       Impact factor: 2.644

3.  Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome.

Authors:  Paola Izzo; Marina De Rosa; Lorella Paparo; Giovanni Battista Rossi; Paolo Delrio; Daniela Rega; Francesca Duraturo; Raffaella Liccardo; Mario Debellis
Journal:  Hered Cancer Clin Pract       Date:  2013-07-25       Impact factor: 2.857

4.  Muscle hemangiomatosis presenting as a severe feature in a patient with the pten mutation: expanding the phenotype of vascular malformations in bannayan-riley-ruvalcaba syndrome.

Authors:  Y Soysal; T Acun; Cm Lourenço; W Marques; Mc Yakıcıer
Journal:  Balkan J Med Genet       Date:  2012-06       Impact factor: 0.519

Review 5.  PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline.

Authors:  Michaela Plamper; Bettina Gohlke; Joachim Woelfle
Journal:  Mol Cell Pediatr       Date:  2022-02-21

6.  Neuroimaging abnormalities in patients with Cowden syndrome: Retrospective single-center study.

Authors:  Radhika Dhamija; Steven M Weindling; Alyx B Porter; Leland S Hu; Christopher P Wood; Joseph M Hoxworth
Journal:  Neurol Clin Pract       Date:  2018-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.